The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine-Global Market Insights and Sales Trends 2025
Synopsis
PRRS, also known as Porcine Reproductive and Respiratory Syndrome, is a viral disease that occurs worldwide in all age groups. PRRD has two symptoms: reproductive failure or failure in breeding animals, and respiratory disease in pigs of any age.
The global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine in various end use industries. The expanding demands from the Gilts and Sows, are propelling PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market. CH-1R Strain, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the PC Strain segment is estimated at % CAGR for the next seven-year period.
Rising awareness about PRRS is driving the growth of the market. Another opportunity for the market includes increasing animal care spending and R&D activities in the veterinary biologics segment. Vaccinated pigs are expected to significantly reduce the frequency of wild-type virus transmission, helping to prevent dangerous diseases. Additionally, rising government investment is also expected to boost global demand for veterinary autologous vaccines during the forecast period. However, R&D costs may hinder the growth of the market.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine covered in this report include Merck, HIPRA, Sinopharm Animal Health Co., Ltd, Ceva Santé Animale, CAVAC, Bioveta, Jinyu Bio-Technology, Zoetis and Boehringer Ingelheim, etc.
The global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck
HIPRA
Sinopharm Animal Health Co., Ltd
Ceva Santé Animale
CAVAC
Bioveta
Jinyu Bio-Technology
Zoetis
Boehringer Ingelheim
Harbin Pharmaceutical Group
Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market, Segment by Type:
CH-1R Strain
PC Strain
Others
Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market, by Application
Gilts
Sows
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
PRRS, also known as Porcine Reproductive and Respiratory Syndrome, is a viral disease that occurs worldwide in all age groups. PRRD has two symptoms: reproductive failure or failure in breeding animals, and respiratory disease in pigs of any age.
The global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine in various end use industries. The expanding demands from the Gilts and Sows, are propelling PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market. CH-1R Strain, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the PC Strain segment is estimated at % CAGR for the next seven-year period.
Rising awareness about PRRS is driving the growth of the market. Another opportunity for the market includes increasing animal care spending and R&D activities in the veterinary biologics segment. Vaccinated pigs are expected to significantly reduce the frequency of wild-type virus transmission, helping to prevent dangerous diseases. Additionally, rising government investment is also expected to boost global demand for veterinary autologous vaccines during the forecast period. However, R&D costs may hinder the growth of the market.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine covered in this report include Merck, HIPRA, Sinopharm Animal Health Co., Ltd, Ceva Santé Animale, CAVAC, Bioveta, Jinyu Bio-Technology, Zoetis and Boehringer Ingelheim, etc.
The global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck
HIPRA
Sinopharm Animal Health Co., Ltd
Ceva Santé Animale
CAVAC
Bioveta
Jinyu Bio-Technology
Zoetis
Boehringer Ingelheim
Harbin Pharmaceutical Group
Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market, Segment by Type:
CH-1R Strain
PC Strain
Others
Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market, by Application
Gilts
Sows
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Overview
1.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Overview
1.2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Segment by Type
1.2.1 CH-1R Strain
1.2.2 PC Strain
1.2.3 Others
1.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Type
1.3.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Overview by Type (2018-2029)
1.3.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Historic Market Size Review by Type (2018-2023)
1.3.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Breakdown by Type (2018-2023)
1.4.2 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Breakdown by Type (2018-2023)
2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Competition by Company
2.1 Global Top Players by PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (2018-2023)
2.2 Global Top Players by PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2018-2023)
2.3 Global Top Players by PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price (2018-2023)
2.4 Global Top Manufacturers PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Competitive Situation and Trends
2.5.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market
2.8 Key Manufacturers PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Status and Outlook by Region
3.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Historic Market Size by Region
3.2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales in Volume by Region (2018-2023)
3.2.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales in Value by Region (2018-2023)
3.2.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Forecasted Market Size by Region
3.3.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales in Volume by Region (2024-2029)
3.3.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales in Value by Region (2024-2029)
3.3.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Application
4.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Segment by Application
4.1.1 Gilts
4.1.2 Sows
4.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Application
4.2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Overview by Application (2018-2029)
4.2.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Historic Market Size Review by Application (2018-2023)
4.2.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Breakdown by Application (2018-2023)
4.3.2 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Breakdown by Application (2018-2023)
4.3.4 Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Breakdown by Application (2018-2023)
5 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Country
5.1 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Historic Market Size by Country
5.1.1 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales in Volume by Country (2018-2023)
5.1.3 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales in Value by Country (2018-2023)
5.2 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Forecasted Market Size by Country
5.2.1 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales in Volume by Country (2024-2029)
5.2.2 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales in Value by Country (2024-2029)
6 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Country
6.1 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Historic Market Size by Country
6.1.1 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales in Volume by Country (2018-2023)
6.1.3 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales in Value by Country (2018-2023)
6.2 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Forecasted Market Size by Country
6.2.1 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales in Volume by Country (2024-2029)
6.2.2 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales in Value by Country (2024-2029)
7 Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Region
7.1 Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales in Value by Region (2024-2029)
8 Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Country
8.1 Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Historic Market Size by Country
8.1.1 Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales in Volume by Country (2018-2023)
8.1.3 Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales in Value by Country (2018-2023)
8.2 Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Forecasted Market Size by Country
8.2.1 Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales in Volume by Country (2024-2029)
8.2.2 Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales in Value by Country (2024-2029)
9 Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Country
9.1 Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Information
10.1.2 Merck Introduction and Business Overview
10.1.3 Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Products Offered
10.1.5 Merck Recent Development
10.2 HIPRA
10.2.1 HIPRA Company Information
10.2.2 HIPRA Introduction and Business Overview
10.2.3 HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Products Offered
10.2.5 HIPRA Recent Development
10.3 Sinopharm Animal Health Co., Ltd
10.3.1 Sinopharm Animal Health Co., Ltd Company Information
10.3.2 Sinopharm Animal Health Co., Ltd Introduction and Business Overview
10.3.3 Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Products Offered
10.3.5 Sinopharm Animal Health Co., Ltd Recent Development
10.4 Ceva Santé Animale
10.4.1 Ceva Santé Animale Company Information
10.4.2 Ceva Santé Animale Introduction and Business Overview
10.4.3 Ceva Santé Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Ceva Santé Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Products Offered
10.4.5 Ceva Santé Animale Recent Development
10.5 CAVAC
10.5.1 CAVAC Company Information
10.5.2 CAVAC Introduction and Business Overview
10.5.3 CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Products Offered
10.5.5 CAVAC Recent Development
10.6 Bioveta
10.6.1 Bioveta Company Information
10.6.2 Bioveta Introduction and Business Overview
10.6.3 Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Products Offered
10.6.5 Bioveta Recent Development
10.7 Jinyu Bio-Technology
10.7.1 Jinyu Bio-Technology Company Information
10.7.2 Jinyu Bio-Technology Introduction and Business Overview
10.7.3 Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Products Offered
10.7.5 Jinyu Bio-Technology Recent Development
10.8 Zoetis
10.8.1 Zoetis Company Information
10.8.2 Zoetis Introduction and Business Overview
10.8.3 Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Products Offered
10.8.5 Zoetis Recent Development
10.9 Boehringer Ingelheim
10.9.1 Boehringer Ingelheim Company Information
10.9.2 Boehringer Ingelheim Introduction and Business Overview
10.9.3 Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Products Offered
10.9.5 Boehringer Ingelheim Recent Development
10.10 Harbin Pharmaceutical Group
10.10.1 Harbin Pharmaceutical Group Company Information
10.10.2 Harbin Pharmaceutical Group Introduction and Business Overview
10.10.3 Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Products Offered
10.10.5 Harbin Pharmaceutical Group Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industrial Chain Analysis
11.4 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Dynamics
11.4.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Trends
11.4.2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Drivers
11.4.3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Challenges
11.4.4 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Distributors
12.3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
